(Boursier.com) — Medtronic has revised its profit estimates for the financial year upwards for the second time this year. The group anticipates sustained demand for its medical devices. It forecasts adjusted earnings per share ranging from $5.13 to $5.19 for the year. Organic sales growth is now expected at 4.75%, compared to 4.5% previously. For its second fiscal quarter 2024, ended at the end of October 2023, the group achieved revenues of $8 billion, an increase of 5.3% in consolidated data and 5% organically. Adjusted earnings per share were $1.25. The consensus was for $1.18 adjusted EPS on $7.92 billion in revenue.
©2023 Boursier.com